Australia markets open in 6 hours 29 minutes

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
194.50-1.50 (-0.77%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 15.81B
Enterprise value 14.40B
Trailing P/E 35.99
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.90
Price/book (mrq)8.48
Enterprise value/revenue 17.89
Enterprise value/EBITDA 25.23

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 312.00%
S&P500 52-week change 324.71%
52-week high 3208.18
52-week low 3154.55
50-day moving average 3188.27
200-day moving average 3184.10

Share statistics

Avg vol (3-month) 3701.7k
Avg vol (10-day) 3981.3k
Shares outstanding 580.67M
Implied shares outstanding 680.67M
Float 857.57M
% held by insiders 139.06%
% held by institutions 12.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46
Forward annual dividend yield 43.06%
Trailing annual dividend rate 35.45
Trailing annual dividend yield 32.78%
5-year average dividend yield 4N/A
Payout ratio 433.27%
Dividend date 3N/A
Ex-dividend date 429 May 2024
Last split factor 21100:1000
Last split date 329 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 55.40%
Operating margin (ttm)44.25%

Management effectiveness

Return on assets (ttm)11.36%
Return on equity (ttm)23.64%

Income statement

Revenue (ttm)804.84M
Revenue per share (ttm)9.88
Quarterly revenue growth (yoy)39.70%
Gross profit (ttm)N/A
EBITDA 404.56M
Net income avi to common (ttm)445.92M
Diluted EPS (ttm)5.45
Quarterly earnings growth (yoy)-80.80%

Balance sheet

Total cash (mrq)1.42B
Total cash per share (mrq)17.64
Total debt (mrq)9.53M
Total debt/equity (mrq)0.51%
Current ratio (mrq)6.57
Book value per share (mrq)23.12

Cash flow statement

Operating cash flow (ttm)417.62M
Levered free cash flow (ttm)274.27M